Table S3 from TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy
Autor: | Kenichi Matsuo, Masayoshi Fukuoka, Yayoi Takao, Khoon Tee Chong, Junko Taguchi, Hitoshi Miyakoshi, Seiji Miyahara, Eiji Matsushima, Kunihiro Yoshisue, Akio Fujioka, Keisuke Yamamura, Takeshi Wakasa, Tatsushi Yokogawa, Wakako Yano |
---|---|
Rok vydání: | 2023 |
Popis: | Median survival times in a CFPAC-1 peritoneal dissemination model after S-1, TAS-114, or S-1 and TAS-114 combination treatment |
Databáze: | OpenAIRE |
Externí odkaz: |